Clinical Trial Update: Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

View source ↗

Summary

This document announces an ongoing registry and sample resource at Ohio State University Comprehensive Cancer Center for plasma cell dyscrasias, including multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma
• Plasma Cell Dyscrasias

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Plasma Cell Dyscrasias, Monoclonal Gammopathy of Undetermined Significance | Status: RECRUITING